NEW YORK – A genomic analysis of gallbladder cancer has uncovered alterations that could be therapeutic, including candidates for a cancer vaccine.
Researchers from the US- and India-based MedGenome, Genentech, and multiple international institutions analyzed more than 200 gallbladder cancer samples from patients in Chile, India, and South Korea. Gallbladder cancer affects more than 178,000 people each year and is highly fatal, with a median survival of less than a year and no targeted therapies. It is more common among populations in Asia and South America.